Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Eliem Therapeutics
Biotech
Climb Bio ascends from Eliem legacy, buying IgA antibody for $9M
Eliem Therapeutics is continuing its transformation into an immune-mediated company by paying $9 million for a Chinese biotech’s preclinical antibody.
James Waldron
Jan 9, 2025 10:07am
Cell-focused Sana scoops first CSO—Chutes & Ladders
Aug 30, 2024 8:30am
Double autoimmune acquisitions as Century, Eliem pick up peers
Apr 11, 2024 9:06am
Eliem cuts in on Tango, proposing acquisition after review
Mar 19, 2024 10:57am
Eliem shuts down final drug program 5 months after major layoffs
Jul 20, 2023 9:05am
Eliem axes depression drug, lays off 55% of team to stretch cash
Feb 10, 2023 6:00am
